Results 91 to 100 of about 20,620,162 (309)

PREVALANCE OF HYPENTENSION IN HEMODIALYSIS PATIENTS AND THE IMPORTANCE OF VOLUME CONTROL

open access: yesTurkish Journal of Nephrology, 2019
Hypertension (HT) is very common in hemodialysis (HD) patients, and this is the most important factor that increase cardiovascular morbidity and mortality.
Lütfullah ALTINTEPE   +4 more
doaj  

Optimization of fluid volume control in hemodialysis using federated learning [PDF]

open access: yesBulletin of Natural Sciences Research
Overhydration (OH) represents a significant challenge for hemodialysis patients, significantly affecting the outcomes of their treatment. Accurate prediction and management of overhydration are key to optimizing therapy and improving patients' quality of
Đorđević Suzana   +4 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Data volume control experiment.

open access: yes, 2015
Data volume control experiment.
Chunxian Wu (709171), Wei Zheng (25452)
core   +1 more source

Therapeutic and prognostic predictive value of the Control Volume severity grade on proximal humerus fractures due to bone fragility. [PDF]

open access: yesOrthop Rev (Pavia), 2022
Russo R   +9 more
europepmc   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy